Nice post Zen, Covalon also has introduced ColActive transfer which is targeting the Negative Pressure Wound Therapy market. I did a little reading on NPWT and it sounds like a fast growing method in the wound care field.
I've sold some shares at recent prices over $2, but I still have a lot of stock. I just don't have a good handle on the competitive advantages of the various products and have had zero success in reaching management.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.